{"pmid":32434254,"title":"Challenges at the Time of COVID-19: Opportunities and Innovations in Antivirals from Nature.","text":["Challenges at the Time of COVID-19: Opportunities and Innovations in Antivirals from Nature.","As viral infections are an increasing threat to human societies, the need for new therapeutic strategies is becoming even more obvious. As no vaccine is available for COVID-19, the development of directly acting antiviral agents and preventive strategies have to be considered. Nature provides a huge reservoir of anti-infectious compounds, from which we can deduce innovative ideas, therapies, and products. Anti-adhesive natural products interact with the receptor-mediated recognition and early interaction of viruses with the host cells, leading to a reduced internalisation of the virus and reduced infections (e.g., procyanidin-B-2-di-O-gallate against influenza and herpes virus). Lignans like podophyllotoxin and bicyclol show strong antiviral activities against different viruses, and essential oils can directly interact with viral membranes and reduce the host's inflammatory responses (e.g., 1,8-cineol). Echinacea extracts stimulate the immune system, and bioavailable alkamides are key players by interacting with immunomodulating cannabinoid receptors. COVID-19 and SARS-CoV-2 infections have, in part, successfully been treated in China by preparations from traditional Chinese medicine and, while it is too early to draw conclusions, some promising data are available. There is huge potential, but intensified research is needed to develop evidence-based medicines with a clearly defined chemical profile. Intensified research and development, and therefore funding, are needed for exploiting nature's reservoir against viral infections. Combined action for basic research, chemistry, pharmacognosy, virology, and clinical studies, but also supply chain, sustainable sourcing, and economic aspects have to be considered. This review calls for intensified innovative science on natural products for the patients and for a healthier world!","Planta Med","Hensel, Andreas","Bauer, Rudolf","Heinrich, Michael","Spiegler, Verena","Kayser, Oliver","Hempel, Georg","Kraft, Karin","32434254"],"abstract":["As viral infections are an increasing threat to human societies, the need for new therapeutic strategies is becoming even more obvious. As no vaccine is available for COVID-19, the development of directly acting antiviral agents and preventive strategies have to be considered. Nature provides a huge reservoir of anti-infectious compounds, from which we can deduce innovative ideas, therapies, and products. Anti-adhesive natural products interact with the receptor-mediated recognition and early interaction of viruses with the host cells, leading to a reduced internalisation of the virus and reduced infections (e.g., procyanidin-B-2-di-O-gallate against influenza and herpes virus). Lignans like podophyllotoxin and bicyclol show strong antiviral activities against different viruses, and essential oils can directly interact with viral membranes and reduce the host's inflammatory responses (e.g., 1,8-cineol). Echinacea extracts stimulate the immune system, and bioavailable alkamides are key players by interacting with immunomodulating cannabinoid receptors. COVID-19 and SARS-CoV-2 infections have, in part, successfully been treated in China by preparations from traditional Chinese medicine and, while it is too early to draw conclusions, some promising data are available. There is huge potential, but intensified research is needed to develop evidence-based medicines with a clearly defined chemical profile. Intensified research and development, and therefore funding, are needed for exploiting nature's reservoir against viral infections. Combined action for basic research, chemistry, pharmacognosy, virology, and clinical studies, but also supply chain, sustainable sourcing, and economic aspects have to be considered. This review calls for intensified innovative science on natural products for the patients and for a healthier world!"],"journal":"Planta Med","authors":["Hensel, Andreas","Bauer, Rudolf","Heinrich, Michael","Spiegler, Verena","Kayser, Oliver","Hempel, Georg","Kraft, Karin"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32434254","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1055/a-1177-4396","locations":["Lignans","China","Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1667342288312860672,"score":9.490897,"similar":[{"pmid":32248575,"title":"Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data.","text":["Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data.","Several corona viral infections have created serious threats in the last couple of decades claiming the death of thousands of human beings. Recently, corona viral epidemic raised the issue of developing effective antiviral agents at the earliest to prevent further losses. Natural products have always played a crucial role in drug development process against various diseases, which resulted in screening of such agents to combat emergent mutants of corona virus. This review focuses on those natural compounds that showed promising results against corona viruses. Although inhibition of viral replication is often considered as a general mechanism for antiviral activity of most of the natural products, studies have shown that some natural products can interact with key viral proteins that are associated with virulence. In this context, some of the natural products have antiviral activity in the nanomolar concentration (e.g., lycorine, homoharringtonine, silvestrol, ouabain, tylophorine, and 7-methoxycryptopleurine) and could be leads for further drug development on their own or as a template for drug design. In addition, a good number of natural products with anti-corona virus activity are the major constituents of some common dietary supplements, which can be exploited to improve the immunity of the general population in certain epidemics.","Phytother Res","Islam, Muhammad T","Sarkar, Chandan","El-Kersh, Dina M","Jamaddar, Sarmin","Uddin, Shaikh J","Shilpi, Jamil A","Mubarak, Mohammad S","32248575"],"abstract":["Several corona viral infections have created serious threats in the last couple of decades claiming the death of thousands of human beings. Recently, corona viral epidemic raised the issue of developing effective antiviral agents at the earliest to prevent further losses. Natural products have always played a crucial role in drug development process against various diseases, which resulted in screening of such agents to combat emergent mutants of corona virus. This review focuses on those natural compounds that showed promising results against corona viruses. Although inhibition of viral replication is often considered as a general mechanism for antiviral activity of most of the natural products, studies have shown that some natural products can interact with key viral proteins that are associated with virulence. In this context, some of the natural products have antiviral activity in the nanomolar concentration (e.g., lycorine, homoharringtonine, silvestrol, ouabain, tylophorine, and 7-methoxycryptopleurine) and could be leads for further drug development on their own or as a template for drug design. In addition, a good number of natural products with anti-corona virus activity are the major constituents of some common dietary supplements, which can be exploited to improve the immunity of the general population in certain epidemics."],"journal":"Phytother Res","authors":["Islam, Muhammad T","Sarkar, Chandan","El-Kersh, Dina M","Jamaddar, Sarmin","Uddin, Shaikh J","Shilpi, Jamil A","Mubarak, Mohammad S"],"date":"2020-04-06T11:00:00Z","year":2020,"_id":"32248575","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1002/ptr.6700","keywords":["coronavirus","humans health","phytochemicals"],"e_drugs":["tylophorine","Ouabain","lycorine","7-methoxycryptopleurine","silvestrol","Homoharringtonine"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138492015476736,"score":225.67729},{"pmid":32363255,"pmcid":"PMC7123907","title":"Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil.","text":["Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil.","Eighteen active substances, including 17 organosulfur compounds found in garlic essential oil (T), were identified by GC-MS analysis. For the first time, using the molecular docking technique, we report the inhibitory effect of the considered compounds on the host receptor angiotensin-converting enzyme 2 (ACE2) protein in the human body that leads to a crucial foundation about coronavirus resistance of individual compounds on the main protease (PDB6LU7) protein of SARS-CoV-2. The results show that the 17 organosulfur compounds, accounting for 99.4% contents of the garlic essential oil, have strong interactions with the amino acids of the ACE2 protein and the main protease PDB6LU7 of SARS-CoV-2. The strongest anticoronavirus activity is expressed in allyl disulfide and allyl trisulfide, which account for the highest content in the garlic essential oil (51.3%). Interestingly, docking results indicate the synergistic interactions of the 17 substances, which exhibit good inhibition of the ACE2 and PDB6LU7 proteins. The results suggest that the garlic essential oil is a valuable natural antivirus source, which contributes to preventing the invasion of coronavirus into the human body.","ACS Omega","Thuy, Bui Thi Phuong","My, Tran Thi Ai","Hai, Nguyen Thi Thanh","Hieu, Le Trung","Hoa, Tran Thai","Thi Phuong Loan, Huynh","Triet, Nguyen Thanh","Anh, Tran Thi Van","Quy, Phan Tu","Tat, Pham Van","Hue, Nguyen Van","Quang, Duong Tuan","Trung, Nguyen Tien","Tung, Vo Thanh","Huynh, Lam K","Nhung, Nguyen Thi Ai","32363255"],"abstract":["Eighteen active substances, including 17 organosulfur compounds found in garlic essential oil (T), were identified by GC-MS analysis. For the first time, using the molecular docking technique, we report the inhibitory effect of the considered compounds on the host receptor angiotensin-converting enzyme 2 (ACE2) protein in the human body that leads to a crucial foundation about coronavirus resistance of individual compounds on the main protease (PDB6LU7) protein of SARS-CoV-2. The results show that the 17 organosulfur compounds, accounting for 99.4% contents of the garlic essential oil, have strong interactions with the amino acids of the ACE2 protein and the main protease PDB6LU7 of SARS-CoV-2. The strongest anticoronavirus activity is expressed in allyl disulfide and allyl trisulfide, which account for the highest content in the garlic essential oil (51.3%). Interestingly, docking results indicate the synergistic interactions of the 17 substances, which exhibit good inhibition of the ACE2 and PDB6LU7 proteins. The results suggest that the garlic essential oil is a valuable natural antivirus source, which contributes to preventing the invasion of coronavirus into the human body."],"journal":"ACS Omega","authors":["Thuy, Bui Thi Phuong","My, Tran Thi Ai","Hai, Nguyen Thi Thanh","Hieu, Le Trung","Hoa, Tran Thai","Thi Phuong Loan, Huynh","Triet, Nguyen Thanh","Anh, Tran Thi Van","Quy, Phan Tu","Tat, Pham Van","Hue, Nguyen Van","Quang, Duong Tuan","Trung, Nguyen Tien","Tung, Vo Thanh","Huynh, Lam K","Nhung, Nguyen Thi Ai"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32363255","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1021/acsomega.0c00772","e_drugs":["Disulfides"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138496081854464,"score":171.66795},{"pmid":32191676,"title":"Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity?","text":["Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity?","BACKGROUND: Viral infectivity depends on interactions between components of the host cell plasma membrane and the virus envelope. Here we review strategies that could help stem the advance of the SARS-COV-2 epidemic. METHODS AND RESULTS: We focus on the role of lipid structures, such as lipid rafts and cholesterol, involved in the process, mediated by endocytosis, by which viruses attach to and infect cells. Previous studies have shown that many naturally derived substances, such as cyclodextrin and sterols, could reduce the infectivity of many types of viruses, including the coronavirus family, through interference with lipid-dependent attachment to human host cells. CONCLUSIONS: Certain molecules prove able to reduce the infectivity of some coronaviruses, possibly by inhibiting viral lipid-dependent attachment to host cells. More research into these molecules and methods would be worthwhile as it could provide insights the mechanism of transmission of SARS-COV-2 and, into how they could become a basis for new antiviral strategies.","Acta Biomed","Baglivo, Mirko","Baronio, Manuela","Natalini, Giuseppe","Beccari, Tommaso","Chiurazzi, Pietro","Fulcheri, Ezio","Petralia, Paolo Pietro","Michelini, Sandro","Fiorentini, Giovanni","Miggiano, Giacinto Abele","Morresi, Assunta","Tonini, Gerolamo","Bertelli, Matteo","32191676"],"abstract":["BACKGROUND: Viral infectivity depends on interactions between components of the host cell plasma membrane and the virus envelope. Here we review strategies that could help stem the advance of the SARS-COV-2 epidemic. METHODS AND RESULTS: We focus on the role of lipid structures, such as lipid rafts and cholesterol, involved in the process, mediated by endocytosis, by which viruses attach to and infect cells. Previous studies have shown that many naturally derived substances, such as cyclodextrin and sterols, could reduce the infectivity of many types of viruses, including the coronavirus family, through interference with lipid-dependent attachment to human host cells. CONCLUSIONS: Certain molecules prove able to reduce the infectivity of some coronaviruses, possibly by inhibiting viral lipid-dependent attachment to host cells. More research into these molecules and methods would be worthwhile as it could provide insights the mechanism of transmission of SARS-COV-2 and, into how they could become a basis for new antiviral strategies."],"journal":"Acta Biomed","authors":["Baglivo, Mirko","Baronio, Manuela","Natalini, Giuseppe","Beccari, Tommaso","Chiurazzi, Pietro","Fulcheri, Ezio","Petralia, Paolo Pietro","Michelini, Sandro","Fiorentini, Giovanni","Miggiano, Giacinto Abele","Morresi, Assunta","Tonini, Gerolamo","Bertelli, Matteo"],"date":"2020-03-20T11:00:00Z","year":2020,"_id":"32191676","source":"PubMed","week":"202012|Mar 16 - Mar 22","doi":"10.23750/abm.v91i1.9402","e_drugs":["Cyclodextrins","Cholesterol","Sterols","Lipids"],"topics":["Mechanism","Transmission"],"weight":1,"_version_":1666138490565296128,"score":169.48814},{"pmid":32462996,"title":"Molecular Docking, Simulation and MM-PBSA Studies of Nigella Sativa Compounds: A Computational Quest to identify Potential Natural Antiviral for COVID-19 Treatment.","text":["Molecular Docking, Simulation and MM-PBSA Studies of Nigella Sativa Compounds: A Computational Quest to identify Potential Natural Antiviral for COVID-19 Treatment.","Nigella sativa or black seed is used as a medicinal plant around the globe. Oil and seeds have a long tradition of folklore use in various medicinal and food systems. The conventional therapeutic use of Nigella sativa, in different ways, has been reported in several studies to treat different diseases including influenza, headache, hypertension, diabetes, inflammation, eczema, fever, cough, asthma, bronchitis, and fever. Based on previously reported potential therapeutic uses of N. sativa compounds, and keeping in mind the dire need of time for the development of potent antiviral, a combined docking, ADMET properties calculation, molecular dynamics, and MM-PBSA approaches were applied in the current study to check the therapeutic potentials of N. sativa chief constituents against COVID-19. Among the studied compounds, we found that dithymoquinone (DTQ), with binding affinity of -8.6 kcal/mol compared to a positive control (chloroquine, -7.2 kcal/mol) , has the high potential of binding at SARS-CoV-2:ACE2 interface and thus could be predicted a plausible inhibitor to disrupt viral-host interactions. Molecular dynamics simulation of 100 ns well complemented binding affinity of the compound and revealed strong stability of DTQ at the docked site. Additionally, MM-PBSA also affirms the docking results. Compound DTQ of the present study, if validated in wet lab experiments, could be used to treat COVID-19 and could serve as a lead in the future for development of more effective natural antivirals against COVID-19.","J Biomol Struct Dyn","Ahmad, Sajjad","Abbasi, Hyder Wajid","Shahid, Sara","Gul, Sana","Abbasi, Sumra Wajid","32462996"],"abstract":["Nigella sativa or black seed is used as a medicinal plant around the globe. Oil and seeds have a long tradition of folklore use in various medicinal and food systems. The conventional therapeutic use of Nigella sativa, in different ways, has been reported in several studies to treat different diseases including influenza, headache, hypertension, diabetes, inflammation, eczema, fever, cough, asthma, bronchitis, and fever. Based on previously reported potential therapeutic uses of N. sativa compounds, and keeping in mind the dire need of time for the development of potent antiviral, a combined docking, ADMET properties calculation, molecular dynamics, and MM-PBSA approaches were applied in the current study to check the therapeutic potentials of N. sativa chief constituents against COVID-19. Among the studied compounds, we found that dithymoquinone (DTQ), with binding affinity of -8.6 kcal/mol compared to a positive control (chloroquine, -7.2 kcal/mol) , has the high potential of binding at SARS-CoV-2:ACE2 interface and thus could be predicted a plausible inhibitor to disrupt viral-host interactions. Molecular dynamics simulation of 100 ns well complemented binding affinity of the compound and revealed strong stability of DTQ at the docked site. Additionally, MM-PBSA also affirms the docking results. Compound DTQ of the present study, if validated in wet lab experiments, could be used to treat COVID-19 and could serve as a lead in the future for development of more effective natural antivirals against COVID-19."],"journal":"J Biomol Struct Dyn","authors":["Ahmad, Sajjad","Abbasi, Hyder Wajid","Shahid, Sara","Gul, Sana","Abbasi, Sumra Wajid"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32462996","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1080/07391102.2020.1775129","keywords":["admet","covid-19","dithymoquinone","mm-pbsa","molecular dynamic simulation","nigella sativa"],"e_drugs":["Chloroquine","poly(tetramethylene succinate-co-tetramethylene adipate)","dithymoquinone"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668079521523302400,"score":161.50795},{"pmid":32408699,"title":"Essential Oils as Antiviral Agents. Potential of Essential Oils to Treat SARS-CoV-2 Infection: An In-Silico Investigation.","text":["Essential Oils as Antiviral Agents. Potential of Essential Oils to Treat SARS-CoV-2 Infection: An In-Silico Investigation.","Essential oils have shown promise as antiviral agents against several pathogenic viruses. In this work we hypothesized that essential oil components may interact with key protein targets of the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A molecular docking analysis was carried out using 171 essential oil components with SARS-CoV-2 main protease (SARS-CoV-2 M(pro)), SARS-CoV-2 endoribonucleoase (SARS-CoV-2 Nsp15/NendoU), SARS-CoV-2 ADP-ribose-1''-phosphatase (SARS-CoV-2 ADRP), SARS-CoV-2 RNA-dependent RNA polymerase (SARS-CoV-2 RdRp), the binding domain of the SARS-CoV-2 spike protein (SARS-CoV-2 rS), and human angiotensin-converting enzyme (hACE2). The compound with the best normalized docking score to SARS-CoV-2 M(pro) was the sesquiterpene hydrocarbon (E)-beta-farnesene. The best docking ligands for SARS-CoV Nsp15/NendoU were (E,E)-alpha-farnesene, (E)-beta-farnesene, and (E,E)-farnesol. (E,E)-Farnesol showed the most exothermic docking to SARS-CoV-2 ADRP. Unfortunately, the docking energies of (E,E)-alpha-farnesene, (E)-beta-farnesene, and (E,E)-farnesol with SARS-CoV-2 targets were relatively weak compared to docking energies with other proteins and are, therefore, unlikely to interact with the virus targets. However, essential oil components may act synergistically, essential oils may potentiate other antiviral agents, or they may provide some relief of COVID-19 symptoms.","Int J Mol Sci","Silva, Joyce Kelly R da","Figueiredo, Pablo Luis Baia","Byler, Kendall G","Setzer, William N","32408699"],"abstract":["Essential oils have shown promise as antiviral agents against several pathogenic viruses. In this work we hypothesized that essential oil components may interact with key protein targets of the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A molecular docking analysis was carried out using 171 essential oil components with SARS-CoV-2 main protease (SARS-CoV-2 M(pro)), SARS-CoV-2 endoribonucleoase (SARS-CoV-2 Nsp15/NendoU), SARS-CoV-2 ADP-ribose-1''-phosphatase (SARS-CoV-2 ADRP), SARS-CoV-2 RNA-dependent RNA polymerase (SARS-CoV-2 RdRp), the binding domain of the SARS-CoV-2 spike protein (SARS-CoV-2 rS), and human angiotensin-converting enzyme (hACE2). The compound with the best normalized docking score to SARS-CoV-2 M(pro) was the sesquiterpene hydrocarbon (E)-beta-farnesene. The best docking ligands for SARS-CoV Nsp15/NendoU were (E,E)-alpha-farnesene, (E)-beta-farnesene, and (E,E)-farnesol. (E,E)-Farnesol showed the most exothermic docking to SARS-CoV-2 ADRP. Unfortunately, the docking energies of (E,E)-alpha-farnesene, (E)-beta-farnesene, and (E,E)-farnesol with SARS-CoV-2 targets were relatively weak compared to docking energies with other proteins and are, therefore, unlikely to interact with the virus targets. However, essential oil components may act synergistically, essential oils may potentiate other antiviral agents, or they may provide some relief of COVID-19 symptoms."],"journal":"Int J Mol Sci","authors":["Silva, Joyce Kelly R da","Figueiredo, Pablo Luis Baia","Byler, Kendall G","Setzer, William N"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32408699","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3390/ijms21103426","keywords":["covid-19","antiviral","corona virus","essential oils","molecular docking"],"e_drugs":["Oils, Volatile"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666989866104127488,"score":156.76735}]}